CenterPoint Energy (CNP)

NYSEUtilitiesRegulated ElectricSnapshot 2026-10-15

$40.55+1.88%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge CenterPoint Energy’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+0.1%

+10% or more+5%0%−5%−10% or less

2.09 → 2.09 EPS · FY ending Dec 31, 2027 · 12 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 11 to 12; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

Three key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Effective capital allocation including debt issuance	The company has a clear capital allocation plan including debt issuance.	Intact	Capital allocation deviates from stated strategy or increases financial risk	Qualitative: $700M debt issuance & $4.6B credit facility renewal align with strategy Strong Q2, $700M debt issuance, $4.6B credit facility renewal, and $50M DOE grant support disciplined capital allocation. Context reviewed through Oct 15, 2026Last status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Full-year 2026 EPS near $1.9 per share	It targets full-year 2026 EPS near $1.9 per share.	Under Pressure	EPS falls below $1.89 in FY26	Diluted EPS: $0.37 per share FY2026-Q2; GAAP. Published target: >=1.89 USD_PER_SHARE. Target period is not explicitly aligned with this observation. Source published Jul 28, 20260.37 USD/share · source valueSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 1e555a53-e40a-4de1-8e0d-781dd9faae67. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. CenterPoint has consistently reiterated its 2026 non-GAAP EPS guidance range of $1.89-$1.91, which at midpoint represents about 8% growth over 2025's $1.76 non-GAAP EPS. The company reported non-GAAP EPS of $0.40 in 2026-Q2 and $0.56 in 2026-Q1, supporting trajectory toward guidance. The trajectory is delivering consistent progress toward the stated EPS growth target. Delivery assessment Oct 15, 2026
Sustain revenue growth near analyst consensus of 7% next year	It targets full-year 2026 EPS near $1.9 per share.	Improving	Revenue growth falls below 7% YoY next year	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. CenterPoint has consistently reiterated its 2026 non-GAAP EPS guidance range of $1.89-$1.91, which at midpoint represents about 8% growth over 2025's $1.76 non-GAAP EPS. The company reported non-GAAP EPS of $0.40 in 2026-Q2 and $0.56 in 2026-Q1, supporting trajectory toward guidance. The trajectory is delivering consistent progress toward the stated EPS growth target. Delivery assessment Oct 15, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$2.09

$2.08 → $2.09 · observed estimates

FY2027 revenue$10.35B

$10.40B → $10.35B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$2.08	$10,398,192,608	11 / 10
2026-07-25	$2.09	$10,439,496,590	18 / 12
2026-07-26	$2.09	$10,439,496,590	18 / 12
2026-07-27	$2.09	$10,439,496,590	18 / 12
2026-07-28	$2.09	$10,416,246,861	11 / 9
2026-07-29	$2.09	$10,331,542,284	11 / 9
2026-07-30	$2.09	$10,439,496,590	18 / 12
2026-07-31	$2.09	$10,320,549,084	12 / 9
2026-08-01	$2.09	$10,320,549,084	12 / 9
2026-08-02	$2.09	$10,320,549,084	12 / 9
2026-08-03	$2.09	$10,348,632,420	18 / 12
2026-08-04	$2.09	$10,320,549,084	12 / 9
2026-08-05	$2.09	$10,320,549,084	12 / 9
2026-08-06	$2.09	$10,320,549,084	12 / 9
2026-08-07	$2.09	$10,320,522,017	12 / 9
2026-08-08	$2.09	$10,352,715,750	18 / 12
2026-08-09	$2.09	$10,320,522,017	12 / 9
2026-08-10	$2.09	$10,320,522,017	12 / 9
2026-08-11	$2.09	$10,352,715,750	18 / 12
2026-08-12	$2.09	$10,320,522,017	12 / 9
2026-08-13	$2.09	$10,320,522,017	12 / 9
2026-08-14	$2.09	$10,320,522,017	12 / 9
2026-08-15	$2.09	$10,320,522,017	12 / 9
2026-08-16	$2.09	$10,320,522,017	12 / 9
2026-08-17	$2.09	$10,320,522,017	12 / 9
2026-08-18	$2.09	$10,320,522,017	12 / 9
2026-08-19	$2.09	$10,320,522,017	12 / 9
2026-08-20	$2.09	$10,332,074,351	11 / 9
2026-08-21	$2.09	$10,332,074,351	11 / 9
2026-08-22	$2.09	$10,332,074,351	11 / 9
2026-08-23	$2.09	$10,334,326,631	11 / 9
2026-08-24	$2.09	$10,334,326,631	11 / 9
2026-08-25	$2.09	$10,334,326,631	11 / 9
2026-08-26	$2.09	$10,334,326,631	11 / 9
2026-08-27	$2.09	$10,334,326,631	11 / 9
2026-08-28	$2.09	$10,334,326,631	11 / 9
2026-08-29	$2.09	$10,334,326,631	11 / 9
2026-08-30	$2.09	$10,334,326,631	11 / 9
2026-08-31	$2.09	$10,334,326,631	11 / 9
2026-09-01	$2.09	$10,334,326,631	11 / 9
2026-09-02	$2.09	$10,334,326,631	11 / 9
2026-09-03	$2.09	$10,334,326,631	11 / 9
2026-09-04	$2.09	$10,334,326,631	11 / 9
2026-09-05	$2.09	$10,334,326,631	11 / 9
2026-09-06	$2.09	$10,334,326,631	11 / 9
2026-09-07	$2.09	$10,334,326,631	11 / 9
2026-09-08	$2.09	$10,334,326,631	11 / 9
2026-09-09	$2.09	$10,334,326,631	11 / 9
2026-09-10	$2.09	$10,334,326,631	11 / 9
2026-09-11	$2.09	$10,334,326,631	11 / 9
2026-09-12	$2.09	$10,334,326,631	11 / 9
2026-09-13	$2.09	$10,334,326,631	11 / 9
2026-09-14	$2.09	$10,334,326,631	11 / 9
2026-09-15	$2.09	$10,334,326,631	11 / 9
2026-09-16	$2.09	$10,317,224,582	11 / 9
2026-09-17	$2.09	$10,317,224,582	11 / 9
2026-09-18	$2.09	$10,317,224,582	11 / 9
2026-09-19	$2.09	$10,328,316,735	11 / 10
2026-09-20	$2.09	$10,328,316,735	11 / 10
2026-09-21	$2.09	$10,328,316,735	12 / 10
2026-09-22	$2.09	$10,328,316,735	12 / 10
2026-09-23	$2.09	$10,328,316,735	12 / 10
2026-09-24	$2.09	$10,328,316,735	12 / 10
2026-09-25	$2.09	$10,301,259,796	12 / 10
2026-09-26	$2.09	$10,301,259,796	12 / 10
2026-09-27	$2.09	$10,301,259,796	12 / 10
2026-09-28	$2.09	$10,301,259,796	12 / 10
2026-09-29	$2.09	$10,301,259,796	12 / 10
2026-09-30	$2.09	$10,301,259,796	12 / 10
2026-10-01	$2.09	$10,301,286,863	12 / 10
2026-10-02	$2.09	$10,301,286,863	12 / 10
2026-10-03	$2.09	$10,301,286,863	12 / 10
2026-10-04	$2.09	$10,301,286,863	12 / 10
2026-10-05	$2.09	$10,301,286,863	12 / 10
2026-10-06	$2.09	$10,301,286,863	12 / 10
2026-10-07	$2.09	$10,301,286,863	12 / 10
2026-10-08	$2.09	$10,301,286,863	12 / 10
2026-10-09	$2.09	$10,315,441,533	12 / 10
2026-10-10	$2.09	$10,315,441,533	12 / 10
2026-10-11	$2.09	$10,314,858,200	12 / 10
2026-10-12	$2.09	$10,314,858,200	12 / 10
2026-10-13	$2.09	$10,314,858,200	12 / 10
2026-10-14	$2.09	$10,317,144,259	12 / 10
2026-10-15	$2.09	$10,347,210,086	12 / 10

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	8	9
2026-06-01	8	10
2026-07-01	8	10
2026-08-01	8	10
2026-09-01	9	10
2026-10-01	9	10

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 9 Buy / Strong Buy · 10 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades5 maintains

Recent actions · Sep 16–Oct 15 · 5 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

KeyBancOct 13 · prior Jul 23

$46.00 → $44.00-4.3%

Truist FinancialOct 12 · prior Aug 4

$46.00 → $44.00-4.3%

$0$25.30$50.60

0 raises · 2 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Full-year 2026 EPS near $1.9 per sharePublished status: Under Pressure
Sustain revenue growth near analyst consensus of 7% next yearDirect metric needs a verified mapping

Next proof point

Oct 27, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

0.8%Typical daily move · historical

Downside history

-18.7%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

CenterPoint Energy outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

This investment is in the utility sector, characterized by stable cash flows and regulated returns. The current thesis state reflects a medium confidence level due to recent strong financial performance, but management execution has been volatile.

What's priced into CenterPoint Energy

The market appears to be pricing CNP at a premium compared to its peers, indicating expectations for continued performance. However, there is a slight expectations gap, suggesting that the market does not fully anticipate significant changes in earnings or guidance.

What the fundamentals likely do

CNP is on track to meet its full-year earnings guidance, supported by recent financial results. The company is also executing its capital investment plan, which is crucial for future growth, although there is a low probability of missing guidance in the near term.

What CenterPoint Energy hinges on

The long-term thesis hinges on several factors, including the Federal Reserve's interest rate decisions and the performance of key sector peers. Additionally, any changes in guidance from CNP could significantly impact market perceptions and stock performance.